260
Participants
Start Date
April 20, 2020
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
Medable Inc., Palo Alto
Lead Sponsor
Collaborators (3)
Datavant
INDUSTRY
American Heart Association
OTHER
BioIntelliSense
UNKNOWN
PWNHealth
UNKNOWN
Medable Inc.
OTHER